Skip to content

Comparative Bioavailability of Lisdexamfetamine Dimesylate 70 mg in Healthy Subjects Under Fasting Conditions

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-509808-15-00
Acronym
BLCL-LIS-PIL01
Enrollment
12
Registered
2024-03-13
Start date
2024-04-29
Completion date
2024-05-29
Last updated
2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No medical condition.

Interventions

None listed

Sponsors

Pharmaplot P.C.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Portugal

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026